Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.76M Sell
21,522
-5,324
-20% -$1.3M 0.01% 488
2025
Q4
$6.81M Buy
26,846
+11,125
+71% +$2.79M 0.02% 414
2025
Q3
$3.89M Buy
15,721
+1,424
+10% +$341K 0.01% 488
2025
Q2
$3.44M Sell
14,297
-413
-3% -$96.2K 0.01% 503
2025
Q1
$3.33M Buy
14,710
+912
+7% +$201K 0.01% 517
2024
Q4
$2.84M Buy
13,798
+1,727
+14% +$379K 0.01% 628
2024
Q3
$2.93M Buy
12,071
+4,132
+52% +$966K 0.01% 552
2024
Q2
$1.74M Sell
7,939
-2,270
-22% -$493K 0.01% 605
2024
Q1
$2.29M Sell
10,209
-1,066
-9% -$240K 0.01% 570
2023
Q4
$2.48M Sell
11,275
-4,943
-30% -$1.05M 0.01% 575
2023
Q3
$3.56M Sell
16,218
-24,161
-60% -$5.47M 0.01% 499
2023
Q2
$9.08M Sell
40,379
-6,329
-14% -$1.27M 0.04% 363
2023
Q1
$8.94M Buy
46,708
+27,489
+143% +$5.31M 0.04% 372
2022
Q4
$3.55M Buy
19,219
+10,632
+124% +$1.87M 0.02% 494
2022
Q3
$1.43M Buy
8,587
+62
+0.7% +$12.6K 0.01% 606
2022
Q2
$1.76M Buy
8,525
+460
+6% +$104K 0.01% 566
2022
Q1
$1.95M Buy
8,065
+515
+7% +$119K 0.01% 592
2021
Q4
$1.84M Sell
7,550
-33,990
-82% -$7.77M 0.01% 620
2021
Q3
$8.49M Sell
41,540
-36,050
-46% -$7.71M 0.03% 381
2021
Q2
$16M Sell
77,590
-1,600
-2% -$322K 0.03% 397
2021
Q1
$15.1M Buy
79,190
+18,574
+31% +$3.45M 0.03% 396
2020
Q4
$63.2M Buy
60,616
+11,740
+24% +$2.19M 0.03% 437
2020
Q3
$8.61M Buy
48,876
+25,080
+105% +$4.01M 0.03% 437
2020
Q2
$3.65M Buy
23,796
+12,433
+109% +$1.89M 0.01% 575
2020
Q1
$1.59M Buy
11,363
+1,920
+20% +$287K 0.01% 594
2019
Q4
$1.44M Sell
9,443
-1,391
-13% -$204K 0.01% 774
2019
Q3
$1.56M Buy
+10,834
New +$1.62M 0.01% 720
2013
Q4
Sell
-133,106
Closed -$5.72M 1336
2013
Q3
$5.72M Buy
133,106
+87,329
+191% +$3.79M 0.09% 276
2013
Q2
$1.96M Buy
+45,777
New +$1.97M 0.04% 498

Other funds holding STE

KBC Group's STE Position: Q1 2026 in Review

KBC Group reduced its Steris (STE) stake by 20% in Q1 2026, selling an estimated $1.3M and leaving 21,522 shares worth $4.76M. The position accounts for 0.01% of the portfolio, ranked #488.

KBC Group first reported a position in STE in Q2 2013 and has held it in 29 quarters since. The position peaked at $63.2M in Q4 2020. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • KBC Group held 21,522 shares of Steris worth $4.76M as of Q1 2026.
  • KBC Group sold 5,324 Steris shares in Q1 2026, an estimated $1.3M.
  • Steris made up 0.01% of KBC Group's portfolio in Q1 2026, its #488 holding.
  • KBC Group first reported a position in Steris in Q2 2013 and has held it in 29 quarters since.
  • KBC Group's Steris position peaked at $63.2M in Q4 2020.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.